[fcb5af]: / literature / by_gene / GRB2.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33452442 10.1038/s41380-020-01003-y 2022 Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation. GRB2
2 34429382 10.1126/scisignal.abe2606 2022 Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function. GRB2
3 34589930 10.1016/j.jtocrr.2020.100023 2022 Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report. GRB2
4 35574218 10.18632/oncotarget.28228 2022 Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation. GRB2
5 35895897 10.1182/blood.2022016424 2022 Gab2-MALT1 Axis Regulates Thromboinflammation and Deep Vein Thrombosis. GRB2
6 36037968 10.1016/j.jbc.2022.102419 2022 Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin. GRB2
7 33532178 10.1016/j.apsb.2020.07.010 2021 Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. GRB2
8 33619116 10.1158/0008-5472.CAN-20-2297 2021 NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation. GRB2
9 33627783 10.1038/s41388-021-01684-x 2021 E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis. GRB2
10 33848463 10.1016/j.cell.2021.03.031 2021 Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules. GRB2
11 34409981 10.1042/BCJ20210175 2021 A nexus of miR-1271, PAX4 and ALK/RYK influences the cytoskeletal architectures in Alzheimer's Disease and Type 2 Diabetes. GRB2
12 29556564 10.1016/j.bbrep.2018.01.007 2020 The role of the ShcD and RET interaction in neuroblastoma survival and migration. GRB2
13 31151983 10.1182/blood.2019001043 2020 A novel model of controlling PD-L1 expression in ALK<sup>+</sup> anaplastic large cell lymphoma revealed by CRISPR screening. GRB2
14 31362927 10.1182/bloodadvances.2018016162 2020 Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling. GRB2
15 31789417 10.3892/ijmm.2019.4414 2020 Combination of the ginsenosides Rb3 and Rb2 exerts protective effects against myocardial ischemia reperfusion injury in rats. GRB2
16 30024968 10.1371/journal.ppat.1007111 2019 Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB. GRB2
17 27472394 10.18632/oncotarget.10861 2018 c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus. GRB2
18 26719098 10.1038/leu.2015.357 2017 Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. GRB2
19 26757737 10.1007/s00401-016-1536-2 2017 Genomic characterization of primary central nervous system lymphoma. GRB2
20 28046066 10.1371/journal.ppat.1006120 2017 HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors. GRB2
21 26773044 10.1182/blood-2015-06-653006 2016 Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1. GRB2
22 26781991 10.1158/0008-5472.CAN-15-1512 2016 NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells. GRB2
23 25080849 10.1111/ejh.12427 2015 B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. GRB2
24 25575524 10.4077/CJP.2014.BAD281 2015 Effects of RING-SH2Grb², a chimeric protein containing the E3 ligase domain of Cbl, on the EGFR pathway. GRB2
25 24104394 10.1038/leu.2013.291 2014 MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma. GRB2
26 24297922 10.1073/pnas.1319665110 2014 Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling. GRB2
27 22987556 10.1002/bmb.20643 2013 Problem-solving test: signal transduction in Philadelphia chromosome positive leukemia cells. GRB2
28 21189087 10.1902/jop.2010.100312 2012 Real-time quantitative polymerase chain reaction analysis of patients with refractory chronic periodontitis. GRB2
29 22261070 10.1016/j.bpj.2011.09.058 2012 Analyzing the homeostasis of signaling proteins by a combination of Western blot and fluorescence correlation spectroscopy. GRB2
30 21596750 10.1074/jbc.M110.197525 2011 The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination. GRB2
31 19815557 10.1074/jbc.M109.072660 2010 Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling. GRB2
32 20554525 10.1074/jbc.M110.116327 2010 Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. GRB2
33 20697568 2010 Tnk1/Kos1: a novel tumor suppressor. GRB2
34 18829987 10.1093/intimm/dxn108 2009 CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis. GRB2
35 19285946 10.1016/j.molcel.2009.02.012 2009 SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1. GRB2
36 19716163 10.1016/j.humpath.2009.05.009 2009 Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas. GRB2
37 18059481 10.1038/sj.leu.2405057 2008 Subcellular distribution of p210(BCR-ABL) in CML cell lines and primary CD34+ CML cells. GRB2
38 18483552 10.1371/journal.ppat.1000064 2008 A transgenic Drosophila model demonstrates that the Helicobacter pylori CagA protein functions as a eukaryotic Gab adaptor. GRB2
39 17312329 10.1200/JCO.2006.09.3534 2007 Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. GRB2
40 17341634 10.1196/annals.1378.086 2007 Design and functional activity of phosphopeptides with potential immunomodulating capacity, based on the sequence of Grb2-associated binder 1. GRB2
41 17384277 10.1196/annals.1378.036 2007 Grb2-associated binder 1 (Gab1) adaptor/scaffolding protein regulates Erk signal in human B cells. GRB2
42 17483340 10.1158/0008-5472.CAN-06-4350 2007 The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration. GRB2
43 17489982 10.1111/j.1365-2141.2007.06597.x 2007 Studies of a germinal centre B-cell expressed gene, GCET2, suggest its role as a membrane associated adapter protein. GRB2
44 16105984 10.1182/blood-2005-03-1204 2006 p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. GRB2
45 17075693 10.1007/s00018-006-6346-6 2006 Optimization of the cellular import of functionally active SH2-domain-interacting phosphopeptides. GRB2
46 15735675 10.1038/sj.onc.1208523 2005 Domain-specific function of ShcC docking protein in neuroblastoma cells. GRB2
47 14530346 10.4049/jimmunol.171.8.4227 2004 Dual phosphorylation of phosphoinositide 3-kinase adaptor Grb2-associated binder 2 is responsible for superoxide formation synergistically stimulated by Fc gamma and formyl-methionyl-leucyl-phenylalanine receptors in differentiated THP-1 cells. GRB2
48 14551136 10.1182/blood-2003-07-2617 2004 A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. GRB2
49 14963047 10.1074/jbc.M309234200 2004 Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251. GRB2
50 14968112 10.1038/sj.onc.1207398 2004 Identification of NPM-ALK interacting proteins by tandem mass spectrometry. GRB2
51 15050920 10.1016/s1535-6108(04)00053-4 2004 Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. GRB2
52 12531430 10.1016/s0898-6568(02)00122-5 2003 The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2. GRB2
53 12688310 10.1080/1042819021000037930 2003 High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia. GRB2
54 11888936 2002 Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin. GRB2
55 11919185 10.1074/jbc.M111145200 2002 A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells. GRB2
56 11929787 10.1182/blood.v99.8.2957 2002 The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl. GRB2
57 11943732 10.1016/S0002-9440(10)62574-6 2002 Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity. GRB2
58 12372784 10.1152/ajprenal.00380.2001 2002 Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 -/- mice. GRB2
59 11207269 10.4049/jimmunol.166.5.3167 2001 Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase. GRB2
60 10706082 2000 A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. GRB2
61 10747947 10.1074/jbc.M000689200 2000 Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. GRB2
62 10752981 10.3109/10428190009089430 2000 Gab-family adapter molecules in signal transduction of cytokine and growth factor receptors, and T and B cell antigen receptors. GRB2
63 10838162 10.1016/s0167-4889(00)00035-5 2000 Prolactin stimulation of tyrosyl phosphorylation of Shc proteins in Nb(2) lymphoma cells, but not mammary tissues. GRB2
64 10982827 10.1128/MCB.20.19.7109-7120.2000 2000 New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. GRB2
65 11034601 10.1084/jem.192.8.1115 2000 Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans. GRB2
66 9794256 10.1016/s0898-6568(97)00195-2 1999 Serum and insulin induce a Grb2-dependent shift in agonist affinity of beta-adrenergic receptors. GRB2
67 9416834 10.1038/sj.onc.1201468 1998 Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. GRB2
68 9695962 10.1046/j.1365-2141.1998.00803.x 1998 Haemopoietic transformation by the TEL/ABL oncogene. GRB2
69 9819383 10.1128/MCB.18.12.6951 1998 Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. GRB2
70 9845379 1998 c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells. GRB2
71 9040011 10.1093/intimm/9.2.291 1997 Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway. GRB2
72 9126968 1997 Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. GRB2
73 9233773 10.1038/sj.onc.1201163 1997 Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. GRB2
74 9259313 10.1210/mend.11.9.9980 1997 Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. GRB2
75 9341187 10.1074/jbc.272.43.27362 1997 Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cgamma, Grb2, and Vav after B cell antigen receptor activation. GRB2
76 8632004 10.1074/jbc.271.7.3856 1996 The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. GRB2
77 8633037 10.1073/pnas.93.9.4181 1996 Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). GRB2
78 8710377 1996 Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor. GRB2
79 8770364 10.1111/j.1445-5994.1995.tb02892.x 1996 The cbl oncogene: a novel substrate of protein tyrosine kinases. GRB2
80 8892607 1996 Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. GRB2
81 7553858 10.1016/0092-8674(95)90277-5 1995 Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. GRB2
82 7628388 10.1210/endo.136.8.7628388 1995 Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. GRB2
83 7717978 10.1042/bj3070215 1995 The membrane immunoglobulin receptor utilizes a Shc/Grb2/hSOS complex for activation of the mitogen-activated protein kinase cascade in a B-cell line. GRB2